| 产品详情 |
| Edit |   |
|---|
| Product Name | (S)-SLV 319 |
|---|
| Description | Purity >97%. Central cannabinoid (CB1) receptor antagonists may have potential in the treatment of a number of diseases such as neuro-inflammatory disorders, cognitive disorders, septic shock, obesity, psychosis, addiction, and gastrointestinal disorders. (S)-SLV 319 is a potent and selective CB1 receptor antagonist with Ki values of 7.8 and 7,943 nM for CB1 and peripheral cannabinoid (CB2), respectively. (S)-SLV 319 is less lipophilic (log P = 5.1) and therefore more water soluble than other known CB1 receptor ligands. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4S-phenyl-1H-pyrazole-1-carboximidamide, BMS646256, Ibipinabant, JD5001 |
|---|
| Gene, Accession, CAS # | CAS: 464213-10-3 |
|---|
| Catalog # | LS-H27 |
|---|
| Price | |
|---|
| Order / More Info | (S)-SLV 319 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|